Skip to main content

UBS Group AG

Position in FHTX — Foghorn Therapeutics Inc.

CIK 1610520 ZURICH, V8

Position in FHTX

as of Jun 30, 2026 · filed Aug 13, 2026
Position Value
$54,806
-$307,684 QoQ
Shares Held
11,231
-85.2% QoQ
Ownership
0.019%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#64
of 102 holders
Holding Since
Dec 2020
19 quarters on record
Voting authority Sole 38% Shared 0% None 62%

Common Shares in FHTX Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

UBS Group AG holds $8,751,365,122 across 562 Biotechnology names. FHTX ranks #392 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in FHTX

Export CSV
19 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $54,806 11,231
2026-03-31 $362,490 75,835
2025-12-31 $132,326 24,505
2025-09-30 $170,386 34,844
2025-06-30 $201,159 42,800
2025-03-31 $169,206 46,358
2024-12-31 $176,975 37,495
2024-09-30 $111,068 11,930
2024-06-30 $44,223 7,691
2024-03-31 $136,709 20,374
2023-12-31 $150,807 23,381
2023-09-30 $52,180 10,436
2023-06-30 $86,810 12,331
2023-03-31 $47,485 7,659
2022-12-31 $32,198 5,047
2022-03-31 $44,517 2,923
2021-12-31 $157,642 6,893
2021-03-31 $28,152 2,136
2020-12-31 $45,566 2,248